WESTMINSTER RADAR
Search
My MPs
Menu

Question follow-through · 91869

Hormone Replacement Therapy

To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of the recent FDA advisory committee discussion on the risks and benefits of HRT, on (a) product labelling and (b) patient information; and wheth

answeredDepartment of Health and Social Care

About this written question

A written question asks a government minister for information in writing. Parliament publishes the question and any answer.

Answering body
Department of Health and Social Care
Tabled
17 Nov 2025
Target answer date
19 Nov 2025
Answer
25 Nov 2025 · 8 calendar days after tabling

Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.

More questions by this MP on Health and care

Shared topic keywords suggest a connection; they do not establish a follow-up.

Votes on this topic

These Commons divisions share a topic label. The question did not necessarily lead to a vote.

Recorded timeline

  1. 17 Nov 2025

    Question tabled

    To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of the recent FDA advisory committee discussion on the risks and benefits of HRT, on (a) product labelling and (b) patient information; and wheth

  2. 19 Nov 2025

    Target answer date

    Date supplied by the official written-questions record.

  3. 25 Nov 2025

    Answer published

    The Medicines and Healthcare Products Regulatory Agency (MHRA) is an executive agency of the Department which regulates medicine, medical devices, and blood components for transfusion in the United Kingdom, with responsibility for ensuring that medicines ...

Open official record

Official data retrieved 28 Sept 2026.

Later records

Possible follow-up questions

Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Drugs

18 Nov 2025 · To ask the Secretary of State for Health and Social Care, pursuant to the answer of 8 October 2025 provided to question 76507, (i) how many NICE Technology Appraisal approved therapies are not being provided in contravention of obligations by a) Oxford Un

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Maternity Services

25 Nov 2025 · To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that the National Maternity Taskforce includes balanced representation between (a) professional bodies and (b) families with lived experience of matern

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Tomography

26 Nov 2025 · To ask the Secretary of State for Health and Social Care, what steps he is taking to help ensure that diagnostic imaging in the NHS is reported within 4 weeks.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Givinostat

9 Dec 2025 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of the time taken by NICE to assess Givinostat.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Rare Diseases: Gene Therapies

5 Jan 2026 · To ask the Secretary of State for Health and Social Care, what steps he is taking to support the development of gene therapy treatments for rare genetic diseases such as tyrosinemia and Gaucher disease.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Leukaemia: Blood Tests

5 Jan 2026 · To ask the Secretary of State for Health and Social Care, whether he is taking steps to ensure that all patients with suspected leukaemia symptoms can access a full blood count test within 48 hours, as recommended by the NICE NG12 guidelines.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Maternity Services

9 Jan 2026 · To ask the Secretary of State for Health and Social Care, what support for training and resources his Department is providing to integrated care boards to help implement the NHS England Maternal Care Bundle, published on 6 January 2026.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Givinostat

13 Jan 2026 · To ask the Secretary of State for Health and Social Care, what discussions has he had to help conclude the dialogue between NHS England and the manufacturer of givinostat as part of the NICE appraisal.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Maternity Services: Standards

15 Jan 2026 · To ask the Secretary of State for Health and Social Care, if he will make an assessment of effectiveness of Maternity and Neonatal Voices Partnerships (MNVP), including Oxfordshire MNVP in representing the experience of mothers and families.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

NHS: Disclosure of Information

15 Jan 2026 · To ask the Secretary of State for Health and Social Care, if he will bring forward legislative proposals to introduce protections for (a) whistleblowing patients and (b) patient safety advocates.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Surgery: Waiting Lists

15 Jan 2026 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of activity management plans on patient waiting times for elective surgery.